A database that tracks dubious medical claims.
Response number: 77
Date of response: Oct. 7, 2011
Type of response: Ruling
ASASA dismissed Solal's appeal
Claims dealt with in this response
- Claim no 58: Solal Technologies Increases risk of heart attack, diabetes, depression and arthritis Omega deficiency made on 2010-10-04 - Untested and implausible